This book presents a detailed overview of the development of new viral vector-based vaccines
before discussing two major applications: preventive vaccines for infectious diseases and
therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development
into successful pharmaceutical products and several examples at the advanced pre-clinical or
clinical stage are presented. Nevertheless the most efforts were focused on novel and very
innovative technologies for new generation of vector-based vaccines. Furthermore specific
topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines
are presented. Given its scope the book is a must read for all those involved in vaccine
development both in academia and industrial vaccine development.
